Steven Cohen Bridge Bio Pharma, Inc. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 35,000 shares of BBIO stock, worth $987,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,000
Previous 30,000
16.67%
Holding current value
$987,000
Previous $759,000
17.39%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
290Shares Held
170MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$712 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$708 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$400 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$351 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$171 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.18B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...